Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy

Background: The impact of senior age on prostate cancer (PCa) oncological outcomes following radical prostatectomy (RP) is controversial, and further clinical factors could help stratifying risk categories in these patients. Objective: We tested the association between endogenous testosterone (ET) a...

Full description

Bibliographic Details
Main Authors: Antonio Benito Porcaro, Andrea Panunzio, Alberto Bianchi, Clara Cerrato, Sebastian Gallina, Emanuele Serafin, Giovanni Mazzucato, Stefano Vidiri, Damiano D’Aietti, Rossella Orlando, Davide Brusa, Matteo Brunelli, Salvatore Siracusano, Vincenzo Pagliarulo, Maria Angela Cerruto, Alessandro Tafuri, Alessandro Antonelli
Format: Article
Language:English
Published: SAGE Publishing 2023-02-01
Series:Therapeutic Advances in Urology
Online Access:https://doi.org/10.1177/17562872231154150
_version_ 1828009783663263744
author Antonio Benito Porcaro
Andrea Panunzio
Alberto Bianchi
Clara Cerrato
Sebastian Gallina
Emanuele Serafin
Giovanni Mazzucato
Stefano Vidiri
Damiano D’Aietti
Rossella Orlando
Davide Brusa
Matteo Brunelli
Salvatore Siracusano
Vincenzo Pagliarulo
Maria Angela Cerruto
Alessandro Tafuri
Alessandro Antonelli
author_facet Antonio Benito Porcaro
Andrea Panunzio
Alberto Bianchi
Clara Cerrato
Sebastian Gallina
Emanuele Serafin
Giovanni Mazzucato
Stefano Vidiri
Damiano D’Aietti
Rossella Orlando
Davide Brusa
Matteo Brunelli
Salvatore Siracusano
Vincenzo Pagliarulo
Maria Angela Cerruto
Alessandro Tafuri
Alessandro Antonelli
author_sort Antonio Benito Porcaro
collection DOAJ
description Background: The impact of senior age on prostate cancer (PCa) oncological outcomes following radical prostatectomy (RP) is controversial, and further clinical factors could help stratifying risk categories in these patients. Objective: We tested the association between endogenous testosterone (ET) and risk of PCa progression in elderly patients treated with RP. Design: Data from PCa patients treated with RP at a single tertiary referral center, between November 2014 and December 2019 with available follow-up, were retrospectively evaluated. Methods: Preoperative ET (classified as normal if >350 ng/dl) was measured for each patient. Patients were divided according to a cut-off age of 70 years. Unfavorable pathology consisted of International Society of Urologic Pathology (ISUP) grade group >2, seminal vesicle, and pelvic lymph node invasion. Cox regression models tested the association between clinical/pathological tumor features and risk of PCa progression in each age subgroup. Results: Of 651 included patients, 190 (29.2%) were elderly. Abnormal ET levels were detected in 195 (30.0%) cases. Compared with their younger counterparts, elderly patients were more likely to have pathological ISUP grade group >2 (49.0% versus 63.2%). Disease progression occurred in 108 (16.6%) cases with no statistically significant difference between age subgroups. Among the elderly, clinically progressing patients were more likely to have normal ET levels (77.4% versus 67.9%) and unfavorable tumor grades (90.3% versus 57.9%) than patients who did not progress. In multivariable Cox regression models, normal ET [hazard ratio (HR) = 3.29; 95% confidence interval (CI) = 1.27–8.55; p  = 0.014] and pathological ISUP grade group >2 (HR = 5.62; 95% CI = 1.60–19.79; p  = 0.007) were independent predictors of PCa progression. On clinical multivariable models, elderly patients were more likely to progress for normal ET levels (HR = 3.42; 95% CI = 1.34–8.70; p  = 0.010), independently by belonging to high-risk category. Elderly patients with normal ET progressed more rapidly than those with abnormal ET. Conclusion: In elderly patients, normal preoperative ET independently predicted PCa progression. Elderly patients with normal ET progressed more rapidly than controls, suggesting that longer exposure time to high-grade tumors could adversely impact sequential cancer mutations, where normal ET is not anymore protective on disease progression.
first_indexed 2024-04-10T08:43:59Z
format Article
id doaj.art-b6b16cc61e6d42e2a4231b3ff9791bf2
institution Directory Open Access Journal
issn 1756-2880
language English
last_indexed 2024-04-10T08:43:59Z
publishDate 2023-02-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Urology
spelling doaj.art-b6b16cc61e6d42e2a4231b3ff9791bf22023-02-22T15:03:14ZengSAGE PublishingTherapeutic Advances in Urology1756-28802023-02-011510.1177/17562872231154150Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomyAntonio Benito PorcaroAndrea PanunzioAlberto BianchiClara CerratoSebastian GallinaEmanuele SerafinGiovanni MazzucatoStefano VidiriDamiano D’AiettiRossella OrlandoDavide BrusaMatteo BrunelliSalvatore SiracusanoVincenzo PagliaruloMaria Angela CerrutoAlessandro TafuriAlessandro AntonelliBackground: The impact of senior age on prostate cancer (PCa) oncological outcomes following radical prostatectomy (RP) is controversial, and further clinical factors could help stratifying risk categories in these patients. Objective: We tested the association between endogenous testosterone (ET) and risk of PCa progression in elderly patients treated with RP. Design: Data from PCa patients treated with RP at a single tertiary referral center, between November 2014 and December 2019 with available follow-up, were retrospectively evaluated. Methods: Preoperative ET (classified as normal if >350 ng/dl) was measured for each patient. Patients were divided according to a cut-off age of 70 years. Unfavorable pathology consisted of International Society of Urologic Pathology (ISUP) grade group >2, seminal vesicle, and pelvic lymph node invasion. Cox regression models tested the association between clinical/pathological tumor features and risk of PCa progression in each age subgroup. Results: Of 651 included patients, 190 (29.2%) were elderly. Abnormal ET levels were detected in 195 (30.0%) cases. Compared with their younger counterparts, elderly patients were more likely to have pathological ISUP grade group >2 (49.0% versus 63.2%). Disease progression occurred in 108 (16.6%) cases with no statistically significant difference between age subgroups. Among the elderly, clinically progressing patients were more likely to have normal ET levels (77.4% versus 67.9%) and unfavorable tumor grades (90.3% versus 57.9%) than patients who did not progress. In multivariable Cox regression models, normal ET [hazard ratio (HR) = 3.29; 95% confidence interval (CI) = 1.27–8.55; p  = 0.014] and pathological ISUP grade group >2 (HR = 5.62; 95% CI = 1.60–19.79; p  = 0.007) were independent predictors of PCa progression. On clinical multivariable models, elderly patients were more likely to progress for normal ET levels (HR = 3.42; 95% CI = 1.34–8.70; p  = 0.010), independently by belonging to high-risk category. Elderly patients with normal ET progressed more rapidly than those with abnormal ET. Conclusion: In elderly patients, normal preoperative ET independently predicted PCa progression. Elderly patients with normal ET progressed more rapidly than controls, suggesting that longer exposure time to high-grade tumors could adversely impact sequential cancer mutations, where normal ET is not anymore protective on disease progression.https://doi.org/10.1177/17562872231154150
spellingShingle Antonio Benito Porcaro
Andrea Panunzio
Alberto Bianchi
Clara Cerrato
Sebastian Gallina
Emanuele Serafin
Giovanni Mazzucato
Stefano Vidiri
Damiano D’Aietti
Rossella Orlando
Davide Brusa
Matteo Brunelli
Salvatore Siracusano
Vincenzo Pagliarulo
Maria Angela Cerruto
Alessandro Tafuri
Alessandro Antonelli
Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
Therapeutic Advances in Urology
title Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
title_full Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
title_fullStr Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
title_full_unstemmed Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
title_short Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
title_sort normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
url https://doi.org/10.1177/17562872231154150
work_keys_str_mv AT antoniobenitoporcaro normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT andreapanunzio normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT albertobianchi normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT claracerrato normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT sebastiangallina normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT emanueleserafin normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT giovannimazzucato normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT stefanovidiri normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT damianodaietti normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT rossellaorlando normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT davidebrusa normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT matteobrunelli normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT salvatoresiracusano normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT vincenzopagliarulo normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT mariaangelacerruto normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT alessandrotafuri normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy
AT alessandroantonelli normalpreoperativeendogenoustestosteronelevelspredictprostatecancerprogressioninelderlypatientsafterradicalprostatectomy